Re-irradiation for recurrent glioblastoma multiforme

Area of Science:

• Neuro-oncology
• Radiation Oncology
• Radiosurgery

Background:

• Advances in understanding normal brain tissue tolerance and radiation technology have increased interest in central nervous system (CNS) re-irradiation.
• Historically, concerns regarding late toxicity, specifically radiation necrosis (RN), led to hesitancy in performing repeat CNS radiation.
• Minimal prospective data exists for re-irradiation in recurrent gliomas.

Purpose of the Study:

• To review the rationale and various approaches for CNS re-irradiation in the context of recurrent gliomas.
• To discuss the underlying biology and clinical impact of late CNS toxicity, particularly radiation necrosis.
• To highlight the current state of knowledge and future directions in CNS re-irradiation.

Main Methods:

• Literature review of existing studies on CNS re-irradiation for recurrent gliomas.
• Analysis of data regarding radiation technology advancements and brain tissue tolerance.
• Review of biological mechanisms and clinical presentation of CNS radiation toxicity.

Main Results:

• CNS re-irradiation is becoming a more viable option for recurrent gliomas.
• Understanding of brain tolerance and radiation techniques has evolved, mitigating some past concerns.
• Radiation necrosis remains a significant toxicity concern that requires careful management.

Conclusions:

• CNS re-irradiation offers a potential treatment avenue for recurrent gliomas, supported by technological advancements.
• Further prospective research is needed to optimize re-irradiation strategies and minimize toxicity.
• Managing late CNS toxicity, especially radiation necrosis, is crucial for successful re-irradiation outcomes.